A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract

Table 1 Patient characteristics

Age, median (years)	60.5 (range 37–81)
Gender
Male	24 (57.1)
Female	18 (42.9)
ECOG performance status
0	9 (21.4)
1	27 (64.3)
2	6 (14.3)
Primary tumour
Gallbladder	18
Bile ducts	22
Ampulla of vater	2
Metastatic disease at presentation
Yes	39
No	3